Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
American Journal of Ophthalmology
|
October 3, 2025
Management of Retinopathy of Prematurity in the Anti-VEGF Era: Consensus and Recommendations From the Taiwan Pediatric Retina (TPR) Group
Tso-Ting Lai, Yen-Chih Chen, Sheng-Chu Chi, et al.
Liver Cancer
|
February 12, 2024
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features
Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, et al.
Japanese Journal of Ophthalmology
|
December 10, 2025
Use of brolucizumab in refractory neovascular age-related macular degeneration: characteristics and biomarkers of intraocular inflammation from an Asian real-world study
Chun Pao Chang, Yih-Shiou Hwang, Hung-Da Chou, et al.
Orphanet Journal of Rare Diseases
|
April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups
Tzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Journal of Hepatology
|
March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage
Chun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Hepatology (Baltimore, Md.)
|
October 12, 2013
Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment
Chi-Kuan Chen, Ching-Yao Yang, Kuo-Tai Hua, et al.
Hepatology Communications
|
June 9, 2018
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
Shiu-Feng Huang, Il-Chi Chang, Chih-Chen Hong, et al.
The Journal of Experimental Medicine
|
July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages
Xiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.
Clinical and Molecular Hepatology
|
August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular Carcinoma
I-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
American Journal of Ophthalmology
|
October 3, 2025
Management of Retinopathy of Prematurity in the Anti-VEGF Era: Consensus and Recommendations From the Taiwan Pediatric Retina (TPR) Group
Tso-Ting Lai, Yen-Chih Chen, Sheng-Chu Chi, et al.
Liver Cancer
|
February 12, 2024
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features
Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, et al.
Japanese Journal of Ophthalmology
|
December 10, 2025
Use of brolucizumab in refractory neovascular age-related macular degeneration: characteristics and biomarkers of intraocular inflammation from an Asian real-world study
Chun Pao Chang, Yih-Shiou Hwang, Hung-Da Chou, et al.
Orphanet Journal of Rare Diseases
|
April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups
Tzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Journal of Hepatology
|
March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage
Chun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Hepatology (Baltimore, Md.)
|
October 12, 2013
Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment
Chi-Kuan Chen, Ching-Yao Yang, Kuo-Tai Hua, et al.
Hepatology Communications
|
June 9, 2018
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
Shiu-Feng Huang, Il-Chi Chang, Chih-Chen Hong, et al.
The Journal of Experimental Medicine
|
July 16, 2025
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages
Xiaoyun Li, Sofie Hedlund Møller, Jaeoh Park, et al.
Clinical and Molecular Hepatology
|
August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular Carcinoma
I-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Page
of 15